Montana Startup Turns Microbes Into Well Plugs

Montana's BioSqueeze uses bacteria-formed limestone to seal leaking orphan wells, outperforming cement and winning DARPA recognition

3 Jun 2026

Bacteria are solving a problem that has stumped engineers for decades. BioSqueeze, born in Montana and refined over ten years with Department of Energy backing, deploys naturally occurring microbes to grow crystalline limestone inside leaking wellbores. The result: annular gaps sealed where conventional cement plugs routinely fail. More than 200 successful treatments across the US and Canada put the technology well past the pilot stage.

Federal recognition followed. In February 2026, DARPA published a formal success story on BioSqueeze's Microbially Induced Calcium Carbonate Precipitation process through its SBIR program. A full-scale demonstration at Camp Lejeune in April 2025 hardened a large beach section to handle over 800 military vehicle passes, with US Army Corps of Engineers analysts confirming results exceeded performance thresholds.

Commercial momentum has matched that credibility. Operating across nine US states and two Canadian provinces, the company has grown from four founders to 40 employees on $9.45 million in Series A financing. Its rigless DPAS system reports annular methane leak elimination rates more than three times those of conventional cement, making it a practical option for the hardest wellbores to remediate.

On a national scale, cost matters enormously. At a median of $76,000 per well, and far more when failed cement requires drill-out before re-plugging, orphan well programs managing 120,000 to 130,000 documented wells face a GAO-estimated $300 billion liability. Technologies that seal on the first attempt are not a luxury.

Gaps remain. Biomineralization is not yet independently validated across every downhole environment, and most performance data originates from the company's own operational record. Peer-reviewed evidence in high-pressure or high-salinity formations remains an active research priority. Broader cross-institutional validation would sharpen the case for wider adoption.

State programs staring down a cleanup bill measured in the hundreds of billions are already paying close attention.